Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis.

Dexter C, Murray GL, Paulsen IT, Peleg AY.

Expert Rev Anti Infect Ther. 2015 May;13(5):567-73. doi: 10.1586/14787210.2015.1025055.

PMID:
25850806
2.

Impact of daptomycin resistance on Staphylococcus aureus virulence.

Cameron DR, Mortin LI, Rubio A, Mylonakis E, Moellering RC Jr, Eliopoulos GM, Peleg AY.

Virulence. 2015 Feb 17;6(2):127-31. doi: 10.1080/21505594.2015.1011532.

PMID:
25830650
3.

Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies.

Abbott IJ, Peleg AY.

Semin Respir Crit Care Med. 2015 Feb;36(1):99-110. doi: 10.1055/s-0034-1396929. Epub 2015 Feb 2.

PMID:
25643274
4.

Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Doi Y, Murray GL, Peleg AY.

Semin Respir Crit Care Med. 2015 Feb;36(1):85-98. doi: 10.1055/s-0034-1398388. Epub 2015 Feb 2.

PMID:
25643273
5.

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.

Trials. 2015 Jan 27;16(1):24. doi: 10.1186/s13063-014-0541-9.

6.

Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period.

Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY.

Transpl Infect Dis. 2014 Dec;16(6):887-96. doi: 10.1111/tid.12298. Epub 2014 Oct 9.

PMID:
25298044
7.

Antimicrobial stewardship in residential aged care facilities: need and readiness assessment.

Lim CJ, Kwong M, Stuart RL, Buising KL, Friedman ND, Bennett N, Cheng AC, Peleg AY, Marshall C, Kong DC.

BMC Infect Dis. 2014 Jul 23;14:410. doi: 10.1186/1471-2334-14-410.

8.

Antibiotic prescribing practice in residential aged care facilities--health care providers' perspectives.

Lim CJ, Kwong MW, Stuart RL, Buising KL, Friedman ND, Bennett NJ, Cheng AC, Peleg AY, Marshall C, Kong DC.

Med J Aust. 2014 Jul 21;201(2):98-102. Erratum in: Med J Aust. 2014 Nov 17;201(10):574. Peleg, Anton [corrected to Peleg, Anton Y].

PMID:
25045989
9.

Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study.

Lim CJ, Cheng AC, Kennon J, Spelman D, Hale D, Melican G, Sidjabat HE, Paterson DL, Kong DC, Peleg AY.

J Antimicrob Chemother. 2014 Jul;69(7):1972-80. doi: 10.1093/jac/dku077. Epub 2014 Apr 7.

PMID:
24710025
10.

Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study.

Lim CJ, Cheng AC, Kong DC, Peleg AY.

BMC Infect Dis. 2014 Mar 4;14:126. doi: 10.1186/1471-2334-14-126.

11.

A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway.

Cerqueira GM, Kostoulias X, Khoo C, Aibinu I, Qu Y, Traven A, Peleg AY.

J Infect Dis. 2014 Jul 1;210(1):46-55. Epub 2014 Jan 14.

PMID:
24431277
12.

OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital.

Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, Sandalli C.

Clin Microbiol Infect. 2014 May;20(5):410-5. doi: 10.1111/1469-0691.12338. Epub 2013 Aug 19.

13.

Population genetics and the evolution of virulence in Staphylococcus aureus.

Chua KY, Howden BP, Jiang JH, Stinear T, Peleg AY.

Infect Genet Evol. 2014 Jan;21:554-62. doi: 10.1016/j.meegid.2013.04.026. Epub 2013 Apr 27. Review.

PMID:
23628638
14.

The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.

Howden BP, Peleg AY, Stinear TP.

Infect Genet Evol. 2014 Jan;21:575-82. doi: 10.1016/j.meegid.2013.03.047. Epub 2013 Apr 6. Review.

PMID:
23567819
15.

Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies.

Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY.

Expert Rev Anti Infect Ther. 2013 Apr;11(4):395-409. doi: 10.1586/eri.13.21. Review.

PMID:
23566149
16.

The complete genome and phenome of a community-acquired Acinetobacter baumannii.

Farrugia DN, Elbourne LD, Hassan KA, Eijkelkamp BA, Tetu SG, Brown MH, Shah BS, Peleg AY, Mabbutt BC, Paulsen IT.

PLoS One. 2013;8(3):e58628. doi: 10.1371/journal.pone.0058628. Epub 2013 Mar 19.

17.

The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.

Gao W, Cameron DR, Davies JK, Kostoulias X, Stepnell J, Tuck KL, Yeaman MR, Peleg AY, Stinear TP, Howden BP.

J Infect Dis. 2013 Mar 15;207(6):929-39. doi: 10.1093/infdis/jis772. Epub 2012 Dec 18.

18.

The success of acinetobacter species; genetic, metabolic and virulence attributes.

Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L.

PLoS One. 2012;7(10):e46984. doi: 10.1371/journal.pone.0046984. Epub 2012 Oct 29.

19.

The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting.

Doi Y, Adams-Haduch JM, Peleg AY, D'Agata EM.

Diagn Microbiol Infect Dis. 2012 Sep;74(1):34-8. doi: 10.1016/j.diagmicrobio.2012.05.020. Epub 2012 Jun 20.

20.

The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression.

Uwamahoro N, Qu Y, Jelicic B, Lo TL, Beaurepaire C, Bantun F, Quenault T, Boag PR, Ramm G, Callaghan J, Beilharz TH, Nantel A, Peleg AY, Traven A.

PLoS Genet. 2012;8(4):e1002613. doi: 10.1371/journal.pgen.1002613. Epub 2012 Apr 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk